Pacegenix
PrivateLast Round
Early Stage
VC
Mar 26, 2026
Company Overview
Pacegenix is a biotechnology company that develops precision cardiology therapeutics designed to treat heart rhythm disorders and improve outcomes in patients with complex arrhythmias.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pacegenix Comparables
Compare Pacegenix with similar companies based on industry and business-model similarity.
No public comparables are available for Pacegenix. Request access to learn about comparables coverage.
Request accessPacegenix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Stage VC | Mar 26, 2026 |
Pacegenix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Genesis BioCapital | Early Stage VC, Accelerator |
| Eshelman Ventures | Early Stage VC |
| aMoon | Early Stage VC |
| LDV Partners | Early Stage VC |
Pacegenix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Pacegenix's valuation, stock price, and market status.
Is Pacegenix a public or private company?
Pacegenix is a private company.
What is the current stock price of Pacegenix?
Pacegenix is a private company, so its shares have no public market price. Caplight tracks Pacegenix's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pacegenix worth (valuation)?
Valuation information for Pacegenix is not publicly available.
Can I buy Pacegenix stock?
Pacegenix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pacegenix's last funding round?
Pacegenix's most recent funding round was Early Stage VC on March 26, 2026.
Who are the main investors in Pacegenix?
Key investors in Pacegenix include Genesis BioCapital.
Will Pacegenix IPO soon?
No public IPO plans have been announced for Pacegenix.
How can I track Pacegenix secondary market activity?
Caplight tracks bids, offers, and trades in Pacegenix's shares on secondary markets.